Matthew L. Nilles - Publications

Affiliations: 
1998-2021 Biomedical Sciences University of North Dakota School of Medicine and Health Sciences 
Area:
plague, type 3 secretion, innate immune responses

24/39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Arifuzzaman M, Ang WXG, Choi HW, Nilles ML, St John AL, Abraham SN. Necroptosis of infiltrated macrophages drives Yersinia pestis dispersal within buboes. Jci Insight. 3. PMID 30232285 DOI: 10.1172/Jci.Insight.122188  0.345
2017 Alvine TD, Bradley DS, Nilles ML. Mouse Immunization with Purified Needle Proteins from Type III Secretion Systems and the Characterization of the Immune Response to These Proteins. Methods in Molecular Biology (Clifton, N.J.). 1531: 193-201. PMID 27837493 DOI: 10.1007/978-1-4939-6649-3_17  0.365
2017 Alvine TD, Osei-Owusu P, Condry DL, Nilles ML. Expression and Purification of N-Terminally His-Tagged Recombinant Type III Secretion Proteins. Methods in Molecular Biology (Clifton, N.J.). 1531: 183-191. PMID 27837492 DOI: 10.1007/978-1-4939-6649-3_16  0.391
2017 Osei-Owusu P, Nilles ML, Bradley DS, Alvine TD. A Method for Characterizing the Type III Secretion System's Contribution to Pathogenesis: Homologous Recombination to Generate Yersinia pestis Type III Secretion System Mutants. Methods in Molecular Biology (Clifton, N.J.). 1531: 155-164. PMID 27837489 DOI: 10.1007/978-1-4939-6649-3_13  0.367
2017 Condry DL, Nilles ML. Analysis of Type III Secretion System Secreted Proteins. Methods in Molecular Biology (Clifton, N.J.). 1531: 93-99. PMID 27837484 DOI: 10.1007/978-1-4939-6649-3_8  0.356
2017 Nilles ML, Condry DL, Osei-Owusu P. Isolation of Type III Secretion System Needle Complexes by Shearing. Methods in Molecular Biology (Clifton, N.J.). 1531: 61-70. PMID 27837481 DOI: 10.1007/978-1-4939-6649-3_5  0.387
2015 Osei-Owusu P, Jessen Condry DL, Toosky M, Roughead W, Bradley DS, Nilles ML. The N terminus of type III secretion needle protein YscF from Yersinia pestis functions to modulate innate immune responses. Infection and Immunity. 83: 1507-22. PMID 25644012 DOI: 10.1128/Iai.02687-14  0.769
2014 Jessen DL, Osei-Owusu P, Toosky M, Roughead W, Bradley DS, Nilles ML. Type III secretion needle proteins induce cell signaling and cytokine secretion via Toll-like receptors. Infection and Immunity. 82: 2300-9. PMID 24643544 DOI: 10.1128/Iai.01705-14  0.646
2014 Jessen DL, Bradley DS, Nilles ML. A type III secretion system inhibitor targets YopD while revealing differential regulation of secretion in calcium-blind mutants of Yersinia pestis. Antimicrobial Agents and Chemotherapy. 58: 839-50. PMID 24247143 DOI: 10.1128/Aac.01170-13  0.693
2008 Reina LD, O'Bryant DM, Matson JS, Nilles ML. LcrG secretion is not required for blocking of Yops secretion in Yersinia pestis. Bmc Microbiology. 8: 29. PMID 18261225 DOI: 10.1186/1471-2180-8-29  0.74
2008 Bartra SS, Styer KL, O'Bryant DM, Nilles ML, Hinnebusch BJ, Aballay A, Plano GV. Resistance of Yersinia pestis to complement-dependent killing is mediated by the Ail outer membrane protein. Infection and Immunity. 76: 612-22. PMID 18025094 DOI: 10.1128/Iai.01125-07  0.684
2007 Hamad MA, Nilles ML. Roles of YopN, LcrG and LcrV in controlling Yops secretion by Yersinia pestis. Advances in Experimental Medicine and Biology. 603: 225-34. PMID 17966419 DOI: 10.1007/978-0-387-72124-8_20  0.592
2007 Hamad MA, Nilles ML. Structure-function analysis of the C-terminal domain of LcrV from Yersinia pestis. Journal of Bacteriology. 189: 6734-9. PMID 17644582 DOI: 10.1128/Jb.00539-07  0.59
2005 Matson JS, Durick KA, Bradley DS, Nilles ML. Immunization of mice with YscF provides protection from Yersinia pestis infections. Bmc Microbiology. 5: 38. PMID 15978133 DOI: 10.1186/1471-2180-5-38  0.659
2004 Nilles ML. Dissecting the structure of LcrV from Yersinia pestis, a truly unique virulence protein. Structure (London, England : 1993). 12: 357-8. PMID 15016350 DOI: 10.1016/J.Str.2004.02.026  0.315
2003 Rosenberg EY, Bertenthal D, Nilles ML, Bertrand KP, Nikaido H. Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein Molecular Microbiology. 48: 1609-1619. PMID 12791142 DOI: 10.1046/J.1365-2958.2003.03531.X  0.702
2002 Deng W, Burland V, Plunkett G, Boutin A, Mayhew GF, Liss P, Perna NT, Rose DJ, Mau B, Zhou S, Schwartz DC, Fetherston JD, Lindler LE, Brubaker RR, Plano GV, ... ... Nilles ML, et al. Genome sequence of Yersinia pestis KIM. Journal of Bacteriology. 184: 4601-11. PMID 12142430 DOI: 10.1128/Jb.184.16.4601-4611.2002  0.692
2002 Matson JS, Nilles ML. Interaction of the Yersinia pestis type III regulatory proteins LcrG and LcrV occurs at a hydrophobic interface. Bmc Microbiology. 2: 16. PMID 12102728 DOI: 10.1186/1471-2180-2-16  0.743
2002 Matson JS, Nilles ML. Bmc Microbiology. 2: 25. DOI: 10.1186/1471-2180-2-25  0.654
2001 Matson JS, Nilles ML. LcrG-LcrV interaction is required for control of Yops secretion in Yersinia pestis. Journal of Bacteriology. 183: 5082-91. PMID 11489861 DOI: 10.1128/Jb.183.17.5082-5091.2001  0.741
1999 Fields KA, Nilles ML, Cowan C, Straley SC. Virulence role of V antigen of Yersinia pestis at the bacterial surface Infection and Immunity. 67: 5395-5408. PMID 10496922 DOI: 10.1128/Iai.67.10.5395-5408.1999  0.682
1998 Nilles ML, Fields KA, Straley SC. The V antigen of Yersinia pestis regulates Yop vectorial targeting as well as Yop secretion through effects on YopB and LcrG Journal of Bacteriology. 180: 3410-3420. PMID 9642196 DOI: 10.1128/Jb.180.13.3410-3420.1998  0.672
1997 Hagman KE, Lucas CE, Balthazar JT, Snyder L, Nilles M, Judd RC, Shafer WM. The MtrD protein of Neisseria gonorrhoeae is a member of the resistance/nodulation/division protein family constituting part of an efflux system. Microbiology (Reading, England). 143: 2117-25. PMID 9245801 DOI: 10.1099/00221287-143-7-2117  0.384
1997 Nilles ML, Williams AW, Skrzypek E, Straley SC. Yersinia pestis LcrV forms a stable complex with LcrG and may have a secretion-related regulatory role in the low-Ca2+ response Journal of Bacteriology. 179: 1307-1316. PMID 9023216 DOI: 10.1128/Jb.179.4.1307-1316.1997  0.678
Low-probability matches (unlikely to be authored by this person)
2017 Henderson TA, Nilles ML. Blue Native Protein Electrophoresis to Study the T3S System Using Yersinia pestis as a Model. Methods in Molecular Biology (Clifton, N.J.). 1531: 33-46. PMID 27837479 DOI: 10.1007/978-1-4939-6649-3_3  0.294
2017 Condry DL, Nilles ML. Introduction to Type III Secretion Systems. Methods in Molecular Biology (Clifton, N.J.). 1531: 1-10. PMID 27837477 DOI: 10.1007/978-1-4939-6649-3_1  0.284
2015 Haese N, Brocato RL, Henderson T, Nilles ML, Kwilas SA, Josleyn MD, Hammerbeck CD, Schiltz J, Royals M, Ballantyne J, Hooper JW, Bradley DS. Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure. Plos Neglected Tropical Diseases. 9: e0003803. PMID 26046641 DOI: 10.1371/Journal.Pntd.0003803  0.27
2017 Nilles ML. Detection of Protein Interactions in T3S Systems Using Yeast Two-Hybrid Analysis. Methods in Molecular Biology (Clifton, N.J.). 1531: 213-222. PMID 27837495 DOI: 10.1007/978-1-4939-6649-3_19  0.267
2017 Fink AL, Williams KL, Harris E, Alvine TD, Henderson T, Schiltz J, Nilles ML, Bradley DS. Dengue virus specific IgY provides protection following lethal dengue virus challenge and is neutralizing in the absence of inducing antibody dependent enhancement. Plos Neglected Tropical Diseases. 11: e0005721. PMID 28686617 DOI: 10.1371/Journal.Pntd.0005721  0.255
2022 Raihan MO, Espelien BM, McGregor BA, Hanson C, Brishti A, Velaris NA, Alvine TD, Bradley DS, Nilles M, Golovko MY, Hur J, Porter JE. Modulation of Inflammatory Signaling Molecules in Antigen-Challenged Human Monocytes in Presence of Adrenergic Agonists. Vaccines. 10. PMID 35214778 DOI: 10.3390/vaccines10020321  0.252
2017 Henderson TA, Nilles ML. In Vivo Photo-Cross-Linking to Study T3S Interactions Demonstrated Using the Yersinia pestis T3S System. Methods in Molecular Biology (Clifton, N.J.). 1531: 47-60. PMID 27837480 DOI: 10.1007/978-1-4939-6649-3_4  0.238
2022 Raihan MO, Espelien BM, Hanson C, McGregor BA, Velaris NA, Alvine TD, Al Golovko S, Bradley DS, Nilles M, Glovko MY, Hur J, Porter JE. Characterization of prostanoids response to Bordetella pertussis antigen BscF and Tdap in LPS-challenged monocytes. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 182: 102452. PMID 35690004 DOI: 10.1016/j.plefa.2022.102452  0.208
2020 O'Donnell KL, Knopick PL, Larsen R, Sarkar S, Nilles ML, Bradley DS. Difference in strain pathogenicity of a septicemic infection in a TLR2 mouse model. Infection and Immunity. PMID 31907194 DOI: 10.1128/IAI.00792-19  0.175
2017 Condry DL, Nilles ML. Identification of the Targets of Type III Secretion System Inhibitors. Methods in Molecular Biology (Clifton, N.J.). 1531: 203-211. PMID 27837494 DOI: 10.1007/978-1-4939-6649-3_18  0.17
2020 O'Donnell KL, Espinosa DA, Puerta-Guardo H, Biering SB, Schiltz J, Nilles ML, Li J, Harris E, Bradley DS. Avian anti-NS1 IgY antibodies neutralize dengue virus infection and protect against lethal dengue virus challenge. Antiviral Research. 104923. PMID 32979401 DOI: 10.1016/j.antiviral.2020.104923  0.118
2019 O'Donnell KL, Meberg B, Schiltz J, Nilles ML, Bradley DS. Zika Virus-Specific IgY Results Are Therapeutic Following a Lethal Zika Virus Challenge without Inducing Antibody-Dependent Enhancement. Viruses. 11. PMID 30917523 DOI: 10.3390/v11030301  0.103
2011 Lambert ND, Langfitt DM, Nilles ML, Bradley DS. Resistance to Yersinia pestis infection decreases with age in B10.T(6R) mice. Infection and Immunity. 79: 4438-46. PMID 21859850 DOI: 10.1128/IAI.05267-11  0.091
2016 Knopick P, Benedict K, Alvine T, Nilles M, Ballantyne J, Terman D, Bradley D. Effect of HLA-DQ presentation on SEG/SEI superantigenic reactivity to a CD4+-mediated anti-tumor response devoid of autoimmune or allogeneic effects. Journal of Clinical Oncology. 34: e21047-e21047. DOI: 10.1200/jco.2016.34.15_suppl.e21047  0.069
2015 Haese N, Brocato RL, Henderson T, Nilles ML, Kwilas SA, Josleyn MD, Hammerbeck CD, Schiltz J, Royals M, Ballantyne J, Hooper JW, Bradley DS. Antiviral biologic produced in DNA vaccine/ goose platform protects hamsters against hantavirus pulmonary syndrome when administered post-exposure Plos Neglected Tropical Diseases. 9. DOI: 10.1371/journal.pntd.0003803  0.062
Hide low-probability matches.